Novo Integrated Sciences (NVOS) Key Ratios

$0.00

$0.00 (0.00%)

As on 01-Sep-2026 16:00EDT

Market cap

info icon

$0 Mln

Revenue (TTM)

info icon

$14 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -20.83 5.75 12.63 7.13
EBIT -- 294.26 -105.86 -223.79 -346.22
Net Profit -- 206.42 -22.05 -217.31 -308.23
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsAug-24Aug-23Aug-22
EBIT-Margin info -152.94-113.15-126.23-64.84-267.75
Net Margin info ----------
Return on equity info -64.75-44.84-81.23-38.17-74.85
Return on Capital info -49.49-34.68-65.98-28.25-54.24
Return on Assets info -40.56-29.07-47.64-24.62-49.41
Debt to Equity (x) info ----0.320.180.45
ROCE

-65.98

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-65.98
-28.25
-54.24
-9.74
-15.19
Peer Median
--
--
--
--
--
ROE

-81.23

--

Profit after tax / Average Net worth * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-81.23
-38.17
-74.85
-12.14
-17.81
Peer Median
--
--
--
--
--
ROA

-47.64

--

Profit after tax / Average Total assets * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-47.64
-24.62
-49.41
-9.17
-14.53
Peer Median
--
--
--
--
--
EBIT Margin

-126.23

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-126.23
-64.84
-267.75
-46.27
-60.65
Peer Median
--
--
--
--
--
Net Margin

-121.32

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-121.32
-105.11
-281.52
-47.95
-62.53
Peer Median
--
--
--
--
--
Revenue Growth

0.06

--

Year on year growth in net sales

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.06
0.07
0.26
0.18
-0.17
Peer Median
--
--
--
--
--
EBIT Growth

-105.86

--

Year on year growth in operating profit (EBIT)

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-105.86
74.06
-629.89
9.68
-2,527.85
Peer Median
--
--
--
--
--
Net Profit Growth

-22.05

--

Year on year growth in profit after tax

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-22.05
60.01
-640.57
9.22
-1,153.92
Peer Median
--
--
--
--
--
Debt to Equity

0.32

--

Total debt / Net worth

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.32
0.18
0.45
0.31
0.15
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.21

--

(Short term borrowings / Net worth)

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.21
0.11
0.17
0.13
0.04
Peer Median
--
--
--
--
--
Current Ratio

0.37

--

Current Assets / Current Liabilities and Provisions

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.37
0.56
1.58
1.32
1.65
Peer Median
--
--
--
--
--
Quick Ratio

0.30

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.30
0.42
1.53
1.28
1.65
Peer Median
--
--
--
--
--
Interest Coverage

-25.72

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-25.72
-1.59
-19.71
-26.10
-30.43
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

23.71

--

Debtors outstanding / Net Sales * 100

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
23.71
11.67
54.31
24.53
25.89
Peer Median
--
--
--
--
--
Asset Turnover

0.39

--

Sales / Average Total Assets

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
0.39
0.23
0.18
0.19
0.23
Peer Median
--
--
--
--
--
Receivable days

63.46

--

Average Debtors / Sales * 365

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
63.46
113.92
134.71
84.74
88.28
Peer Median
--
--
--
--
--
Inventory Days

50.97

--

Average Inventory / Sales * 365

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
50.97
41.99
25.91
11.31
0.00
Peer Median
--
--
--
--
--
Payable days

163.23

--

Average Creditors / Cost of goods sold * 365

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
163.23
123.09
80.84
77.74
77.15
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-48.80

--

Receivable Days + Inventory Days - Payable Days

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-48.80
32.82
79.77
18.31
11.13
Peer Median
--
--
--
--
--
EV/EBITDA

-0.38

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Aug-24
Aug-23
Aug-22
Aug-21
Aug-20
Novo Integrated Sciences (NVOS)
-0.38
-0.69
-0.25
-2.10
-0.84
Peer Median
--
--
--
--
--
loading...
loading...